496.11

0.87% -4.35

Thermo Fisher Scientific Inc (TMO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TMO Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$500.46

Aprire:

$500.11

Volume 24 ore:

1.31M

Relative Volume:

0.57

Capitalizzazione di mercato:

$184.37B

Reddito:

$44.56B

Utile/perdita netta:

$6.72B

Rapporto P/E:

27.97

EPS:

17.7387

Flusso di cassa netto:

$6.29B

1 W Prestazione:

+0.95%

1M Prestazione:

-0.79%

6M Prestazione:

-5.47%

1 anno Prestazione:

+16.07%

Intervallo 1D:

$495.81

$503.81

Intervallo di 1 settimana:

$479.95

$507.27

Portata 52W:

$385.46

$643.99

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Nome

Thermo Fisher Scientific Inc

Settore

Healthcare (1106)

Industria

Diagnostics & Research (52)

Telefono

(781) 622-1000

Indirizzo

168 THIRD AVENUE, WALTHAM, MA

Dipendente

125,000

Cinguettio

@thermofisher

Prossima data di guadagno

2026-04-23

Ultimi documenti SEC

TMO's Discussions on Twitter

Compare TMO vs DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMO Thermo Fisher Scientific Inc	496.11	185.98B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	189.61	136.58B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	563.00	46.44B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	115.06	32.61B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	320.00	31.16B	3.17B	642.63M	516.49M	10.77

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-27	Iniziato	DZ Bank	Buy
2025-12-11	Aggiornamento	Citigroup	Neutral → Buy
2025-12-09	Iniziato	Goldman	Buy
2025-12-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-12-01	Aggiornamento	HSBC Securities	Hold → Buy
2025-09-11	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-19	Iniziato	William Blair	Outperform
2025-07-24	Downgrade	HSBC Securities	Buy → Hold
2025-07-11	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Downgrade	UBS	Buy → Neutral
2025-01-10	Aggiornamento	Bernstein	Mkt Perform → Outperform
2024-12-23	Iniziato	Scotiabank	Sector Perform
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-10-01	Iniziato	Stephens	Overweight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-03	Ripresa	Jefferies	Buy
2024-03-18	Ripresa	Citigroup	Neutral
2024-01-24	Downgrade	Barclays	Overweight → Equal Weight
2024-01-08	Downgrade	Bernstein	Outperform → Mkt Perform
2023-12-18	Iniziato	HSBC Securities	Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-10-26	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2023-09-28	Iniziato	Bernstein	Outperform
2023-09-06	Ripresa	Citigroup	Buy
2023-07-19	Iniziato	Raymond James	Outperform
2023-07-19	Reiterato	Robert W. Baird	Outperform
2023-07-13	Aggiornamento	Credit Suisse	Neutral → Outperform
2023-04-04	Reiterato	Barclays	Overweight
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-27	Downgrade	The Benchmark Company	Buy → Hold
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-04-25	Downgrade	Wells Fargo	Equal Weight → Underweight
2022-01-26	Ripresa	Barclays	Overweight
2021-10-20	Aggiornamento	Citigroup	Neutral → Buy
2021-10-15	Ripresa	Cowen	Outperform
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-16	Iniziato	The Benchmark Company	Buy
2021-03-18	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Iniziato	Barclays	Overweight
2021-01-08	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-12-02	Iniziato	Goldman	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-14	Iniziato	Morgan Stanley	Overweight
2020-08-20	Ripresa	JP Morgan	Overweight
2020-07-15	Aggiornamento	Cleveland Research	Neutral → Buy
2020-07-07	Reiterato	Needham	Buy
2020-04-23	Reiterato	Needham	Buy
2020-01-31	Reiterato	Needham	Buy
2020-01-22	Iniziato	Credit Suisse	Neutral
2020-01-08	Iniziato	Wells Fargo	Equal Weight
2020-01-07	Iniziato	Citigroup	Buy
2019-11-15	Iniziato	Stifel	Buy
2019-07-25	Reiterato	Needham	Buy
2019-07-16	Downgrade	Needham	Strong Buy → Buy
2019-05-30	Iniziato	Wolfe Research	Outperform
2019-05-23	Reiterato	Needham	Strong Buy
2019-04-22	Reiterato	Needham	Strong Buy
2019-04-16	Reiterato	BofA/Merrill	Buy

Mostra tutto

Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie

05:11 AM

Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance

05:11 AM

Apr 10, 2026

Thermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore - BioSpectrum Asia

Apr 10, 2026

The Market Is Selling Everything, but These 5 Stocks Aren’t Breaking Down - Investing.com

Apr 10, 2026

Thermo Fisher Stock May Benefit Following Collaboration With PRECISE - Yahoo Finance

Apr 10, 2026

Flow Cytometry Market is experiencing boost at an infinite speed - openPR.com

Apr 10, 2026

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.

Apr 10, 2026

Apr 09, 2026

Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE - Bitget

Apr 09, 2026

Thermo Fisher Scientific Expands Global Biobank Leadership - National Today

Apr 09, 2026

Thermo Fisher Scientific and Precision Health Research Singapore Enter Strategic Collaboration to Advance Precise-SG100K Study - marketscreener.com

Apr 09, 2026

Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PREC - PharmiWeb.com

Apr 09, 2026

Thermo Fisher, Singapore’s PRECISE Partner on Population-Scale Proteomics Biobank - Contract Pharma

Apr 09, 2026

TMO Partners with Precision Health for Major Biobank Study - GuruFocus

Apr 09, 2026

Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study - BioPharma APAC

Apr 09, 2026

Thermo Fisher Scientific Signs Strategic Deal With Precision Health Research, Singapore to Support PRECISE-SG100K Study - marketscreener.com

Apr 09, 2026

Thermo Fisher partners with Singapore biobank study By Investing.com - Investing.com India

Apr 09, 2026

Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort - Benzinga

Apr 09, 2026

Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics - Business Wire

Apr 09, 2026

Thermo Fisher Saladax TDM Deal Adds Dimension To Diagnostics Growth Story - Yahoo Finance

Apr 09, 2026

Apr 08, 2026

Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch

Apr 08, 2026